From: To: Subject: RE: Epstein Briefing Follow-up Date: Tue, 20 Oct 2020 13:41:53 +0000 Importance: Normal I have 1pm. I'll send out the conference line. From: Sent: Tuesday, October 20, 2020 9:41 AM To: Subject: (EXTERNAL EMAIL) - RE: Epstein Briefing Follow-up Hi all, I am sorry I cannot recall if we settled a time but I am free most of the day, except for 10-10:30 and 12-1. Thank you, From: Sent: Monday, October 19, 2020 5:39 PM To: Subject: RE: Epstein Briefing Follow-up Good afternoon, I am awaiting clearance from other DOJ components on the November 12 date. I have attached a draft of the invitation/RSVP with preliminary comments. We can discuss these tomorrow. Thanks From: Sent: Monday, October 19, 2020 3:14 PM To: Subject: Re: Epstein Briefing Follow-up Hello, EFTA00038022

Hope everyone is doing well. Checking in to see if there are any updates regarding the November 12 date as well as a draft for the invitation? Thanks! Program Manager FBI Victim Services Division From: Sent: Friday, October 16, 2020 2:45 PM To: Subject: Epstein Briefing Follow-up Hello, Following up on today's phone call on a few things: >; • The Miami FO has the All-Employee Conference Room is available for November 5 and 12 (November 11 is Veteran's Day). • Suggestions for invitation: o Clear identification of the briefing purpose; o Date, location of briefing (Time TBD); o Inclusion of support person language; o COVID precautions (see below); o RSVD deadline; and o Request any questions from victims in advance and have them send by a certain date. • Please find attached a few documents from our briefing last fall: o RSVP Questionnaire Blank o Template Letter for 2019 briefings o Name tag key • Miami COVID procedures to enter the building (see attached documents) o Temperature checks o CDC screening questions o Social distancing o Mandatory face masks Please let me know the confirmed date ASAP so I can begin my canvass of the field for Victim Specialists to assist in Miami. I look forward to seeing your DRAFT invitation letter. Thanks, EFTA00038023

EFTA00038024